Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers

Risk-reducing salpingo-oophorectomy (RRSO) is widely used for cancer risk reduction in BRCA1 or BRCA2 (BRCA1/2) mutation carriers. Occult ovarian/fallopian tube cancers (OOC) detected at the time of RRSO have been reported in several studies with wide variability in reported prevalence. We estimated...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Domchek, Susan M., Friebel, Tara M., Garber, Judy E., Isaacs, Claudine, Matloff, Ellen, Eeles, Rosalind, Evans, D. Gareth, Rubinstein, Wendy, Singer, Christian F., Rubin, Stephen, Lynch, Henry T., Daly, Mary B., Weitzel, Jeffrey, Ganz, Patricia A., Pichert, Gabriella, Olopade, Olufunmilayo I., Tomlinson, Gail, Tung, Nadine, Blum, Joanne L., Couch, Fergus, Rebbeck, Timothy R.
التنسيق: Artigo
اللغة:Inglês
منشور في: 2010
الموضوعات:
Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC2949487/
https://ncbi.nlm.nih.gov/pubmed/20180014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-010-0799-x
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة